Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease

被引：50

作者：

Costacou, Tina ^{[1
]}

Levy, Andrew P. ^{[2
]}

机构：

[1] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA

[2] Technion Israel Inst Technol, Technion Fac Med, Haifa, Israel

来源：

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH | 2012年 / 5卷 / 04期

关键词：

Haptoglobin genotype; Cardiovascular disease; Diabetes; VITAMIN-E SUPPLEMENTATION; CORONARY-ARTERY CALCIFICATION; HEMOGLOBIN SCAVENGER RECEPTOR; MIDDLE-AGED INDIVIDUALS; LOW-DENSITY-LIPOPROTEIN; ACUTE-PHASE PROTEINS; BETA-CAROTENE; IN-VITRO; RISK-FACTOR; VASCULAR COMPLICATIONS;

D O I：

10.1007/s12265-012-9361-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Over the past decade, several longitudinal epidemiological studies have brought attention to the haptoglobin genotype and its importance in determining diabetic vascular disease risk. This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the development of cardiovascular disease among individuals with diabetes mellitus.

引用

页码：423 / 435

页数：13

共 112 条

[1]

[Anonymous], 2011, NAT DIAB FACT SHEET

[2]

[Anonymous], 2001, DIETARY REFERENCE IN, DOI DOI 10.1016/S0899-9007(00)00596-7

[3] Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo [J].

Asleh, R ;

Guetta, J ;

Kalet-Litman, S ;

Miller-Lotan, R ;

Levy, AP .

CIRCULATION RESEARCH, 2005, 96 (04) :435-441

[4] Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease [J].

Asleh, R ;

Marsh, S ;

Shilkrut, M ;

Binah, O ;

Guetta, J ;

Lejbkowicz, F ;

Enav, B ;

Shehadeh, N ;

Kanter, Y ;

Lache, O ;

Cohen, O ;

Levy, NS ;

Levy, AP .

CIRCULATION RESEARCH, 2003, 92 (11) :1193-1200

[5] Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype [J].

Asleh, Rabea ;

Blum, Shany ;

Kalet-Litman, Shiri ;

Alshiek, Jonia ;

Miller-Lotan, Rachel ;

Asaf, Roy ;

Rock, Wasseem ;

Aviram, Michael ;

Milman, Uzi ;

Shapira, Chen ;

Abassi, Zaid ;

Levy, Andrew P. .

DIABETES, 2008, 57 (10) :2794-2800

[6] Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo [J].

Asleh, Rabea ;

Miller-Lotan, Rachael ;

Aviram, Michael ;

Hayek, Tony ;

Yulish, Michael ;

Levy, Joanne E. ;

Miller, Benjamin ;

Blum, Shany ;

Milman, Uzi ;

Shapira, Chen ;

Levy, Andrew P. .

CIRCULATION RESEARCH, 2006, 99 (12) :1419-1425

[7] In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease [J].

Asleh, Rabea ;

Levy, Andrew .

VASCULAR HEALTH AND RISK MANAGEMENT, 2005, 1 (01) :19-28

[8] Divergent Effects of α-Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype [J].

Asleh, Rabea ;

Levy, Andrew P. .

ANTIOXIDANTS & REDOX SIGNALING, 2010, 12 (02) :209-217

[9] Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin [J].

Azarov, Ivan ;

He, Xiaojun ;

Jeffers, Anne ;

Basu, Swati ;

Ucer, Burak ;

Hantgan, Roy R. ;

Levy, Andrew ;

Kim-Shapiro, Daniel B. .

NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2008, 18 (04) :296-302

[10] Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype [J].

Blum, Shany ;

Milman, Uzi ;

Shapira, Chen ;

Miller-Lotan, Rachel ;

Bennett, Lawrence ;

Kostenko, Maria ;

Landau, Michele ;

Keidar, Shlomo ;

Levy, Yishai ;

Khemlin, Alexander ;

Radan, Arman ;

Levy, Andrew P. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (03) :E18-E20

← 1 2 3 4 5 6 7 8 9 10 →